Rossari Biotech per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹27.58₹26.95₹24.66₹23.67₹19.46
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹27.55₹26.93₹24.63₹23.62₹19.38
₹240.74₹240.74₹214.12₹189.65₹166.04
₹480.51₹432.67₹375.74₹331.35₹300.43
—₹11.75₹24.82₹7.83₹27.65
−₹36.04−₹36.04−₹3.81−₹15.93₹21.68
—₹0.50₹0.50₹0.50₹0.50
5.55.55.55.55.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ROSSARI₹407.60

Rossari Biotech Limited

· Chemicals
₹ CrorePeersNOCILHSCLNAVINFLUORDDEVPLSTIKCHEMPLASTSTATACHEMAARTIINDJGCHEMMcap ₹2,257 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS19.4623.6724.6626.9527.58
Diluted EPS19.3823.6224.6326.9327.55
Book Value per Share166.04189.65214.12240.74240.74
Revenue per Share300.43331.35375.74432.67480.51
Cash Flow per Share27.657.8324.8211.75—
Free Cash Flow per Share21.68-15.93-3.81-36.04-36.04
Dividends per Share0.500.500.500.50—
Shares Outstanding (cr)5.55.55.55.55.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.